The 2.3% sales tax on U.S. medical device sales would push as many as 146,000 U.S. medtech jobs offshore, conservative economist Diana Furchtgott-Roth tells a Congressional panel.

The medical device tax, a 2.3% levy on all U.S. medtech sales, could push 146,000 jobs overseas, conservative economist Diana Furchtgott-Roth told a U.S. House of Representatives committee this week.
Furchtgott-Roth, a senior fellow at the Manhattan Institute think tank, told the House Energy & Commerce Committee that the medical device tax enacted as part of the Affordable Care Act would "shift production offshore," the Washington Examiner reported.
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3...
Results of pivotal study on Covidien subsidiary eV3's Pipeline cerebral aneurysm device, published in...
Delphi Ventures' John Maroney joins ForSight Vision5 as president, CEO & Director as the...
Echo Therapeutics initiates discussions with the FDA on the regulatory pathway for its Symphony non-...
Study results revealed in Europe this week cast doubt on the efficacy of renal denervation for...